Gene therapy company bringing 200 jobs to Durham

URLhttp://www.newsobserver.com/news/business/article2
SourceThe News & Observer
Date Published05/22/2018
Author NameZachary Eanes
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name AveXis
Parent companyAveXis
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):200
Year reshoring announced:2018
Country(ies) from which reshored:Switzerland
City reshored to:Durham
State(s) reshored to:NC
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredgene therapy spinal muscular dystrophy
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Infrastructure, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training
Government Incentive dollar amount:3
Find Reshoring Articles